News

Jim Cramer Warns that Pfizer “Shareholder Base is Getting Very Restive”
Pfizer Inc. (NYSE:PFE) is one of the stocks in Jim Cramer’s game plan for this week. Cramer mentioned the company during the ...
These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Reasonably Well
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of ...
Buy Pfizer Stock At $24?
Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...
Pfizer rises as Q2 beat leads to guidance raise
Pfizer (NYSE:PFE) stock gains as the company surpasses Q2 2025 expectations with $14.7B revenue and raises its full-year ...
The three-year shareholder returns and company earnings persist lower as Pfizer (NYSE:PFE) stock falls a further 6.1% in past week
For many investors, the main point of stock picking is to generate higher returns than the overall market. But in ...
Why Shares of Pfizer Soared Today
In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...
Pfizer stock pops as big pharma giant delivers post-COVID comeback
Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.
The Pharma Letter18h
Nxera launches new obesity drug pipeline as Pfizer pulls plug
Japanese drugmaker Nxera Pharma has unveiled a slate of new programs targeting obesity and related metabolic diseases, ...